Delivery Order SPE2DB20D3303-SPE2DB24FA0AG

Award Date 6/13/24
Potential Completion Date 6/14/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Revatio 20 mg tablets. The contract has a ceiling value of $38,919.02 and runs through October 7, 2024. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,764.83 firm fixed-price delivery order is for the supply of REVATIO 20 MG tablets and has a completion date of November 5, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,311.29 firm fixed-price delivery order is for the supply of REVATIO 20 MG TABLET 90S, a medication used to treat pulmonary arterial hypertension. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of Revatio 20 mg tablets. The contract has a ceiling value of $6,994.44 and an ultimate completion date of October 16, 2024. It is a firm-fixed-price contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by defense and civilian agencies to provide a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,736.25 firm fixed-price delivery order is for the supply of REVATIO 20 MG tablets. The award is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $15,530.12 firm fixed-price delivery order is for the provision of REVATIO 20 MG TABLET 90S, a medication, with a completion date of June 27, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $17,589.92, is for the supply of Revatio 20 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of August 28, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medications and medical supplies to the U.S. government, including...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product. The contract has a ceiling value of $22,850.43 and a completion date of July 3, 2024. It was awarded on a Firm Fixed Price basis by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The award is a Delivery Order placed against Amerisourcebergen's existing Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $3,063.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of REVATIO 20 MG TABLET 90S, a medication used for the treatment of pulmonary arterial hypertension. The contract has an ultimate completion date of December 17, 2024 and is a Firm Fixed Price contract. This award is not associated with a set-aside...
This federal contract award, with ID SPE2DB22D2206|SPE2DB25FEV36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $18,477.21 contract is a firm fixed-price delivery order for the supply of REVATIO 20 MG TABLET 90S, a medication used to treat pulmonary arterial hypertension. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA0AG
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Revatio 20 mg tablets. The contract has a ceiling value of $2,331.48 and is a firm-fixed-price delivery order with a completion date of June 14, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract does not have a set-aside designation.

Generated 9/12/24, 11:29 AM